Proceedings of the 9th International Conference on Financial Innovation and Economic Development (ICFIED 2024)

Analysis on the Causes and Countermeasures of Business Risks in Health Industry Companies - Based on a Comparative Analysis of Ali Health, United Health Group and Novo Nordisk

Authors
Zhenzi Li1, *, Yuting Pan2, Junyi Zheng2
1Business School, Soochow University, Suzhou, 215021, China
2Business Administration and Management, Broward College, Fort Lauderdale, FL, 33301, USA
*Corresponding author. Email: 2110503055@stu.suda.edu.cn
Corresponding Author
Zhenzi Li
Available Online 7 May 2024.
DOI
10.2991/978-94-6463-408-2_52How to use a DOI?
Keywords
Health Industry; Market Risk; Countermeasures
Abstract

The health industry has always been an important part of the global economy. In recent years, with the improvement of people's living standards, people pay more and more attention to health and quality of lives. After an in-depth study of the market, industry and consumer demand, the health industry has shown the following development trends: health management has gradually become mainstream, the nutrition and healthcare market continue to grow, Internet healthcare has become the new normal, and personalised healthcare service has become the new direction. In the background of the health industry tends to be popular in recent years, this paper selects and analyses the financial statements and stock data of three representative companies, namely, Ali Health, United Health Group and Novo Nordisk. Finding that Novo Nordisk has the lowest business risk, United Health Group is in the middle, and Ali Health has the highest business risk, this paper selects Novo Nordisk and Ali Health as the comparative object to draw the conclusions of the study. On the basis of this research, this paper deeply analyses the causes of different degrees of business risks of the three companies and put forward corresponding countermeasures, which will provide profound guidance for the transformation and upgrading of the traditional health industry as well as for the entry of new enterprises into the health industry in the future.

Copyright
© 2024 The Author(s)
Open Access
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Download article (PDF)

Volume Title
Proceedings of the 9th International Conference on Financial Innovation and Economic Development (ICFIED 2024)
Series
Advances in Economics, Business and Management Research
Publication Date
7 May 2024
ISBN
10.2991/978-94-6463-408-2_52
ISSN
2352-5428
DOI
10.2991/978-94-6463-408-2_52How to use a DOI?
Copyright
© 2024 The Author(s)
Open Access
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Cite this article

TY  - CONF
AU  - Zhenzi Li
AU  - Yuting Pan
AU  - Junyi Zheng
PY  - 2024
DA  - 2024/05/07
TI  - Analysis on the Causes and Countermeasures of Business Risks in Health Industry Companies - Based on a Comparative Analysis of Ali Health, United Health Group and Novo Nordisk
BT  - Proceedings of the 9th International Conference on Financial Innovation and Economic Development (ICFIED 2024)
PB  - Atlantis Press
SP  - 458
EP  - 466
SN  - 2352-5428
UR  - https://doi.org/10.2991/978-94-6463-408-2_52
DO  - 10.2991/978-94-6463-408-2_52
ID  - Li2024
ER  -